These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 24312156)

  • 1. Molecular imaging of inflammation in atherosclerosis.
    Wildgruber M; Swirski FK; Zernecke A
    Theranostics; 2013 Nov; 3(11):865-84. PubMed ID: 24312156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
    Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques.
    Schäfers M; Schober O; Hermann S
    J Nucl Med; 2010 May; 51(5):663-6. PubMed ID: 20439506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory medicine for molecular imaging of atherosclerosis.
    Mangge H; Almer G; Stelzer I; Reininghaus E; Prassl R
    Clin Chim Acta; 2014 Nov; 437():19-24. PubMed ID: 25003647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular magnetic resonance imaging of atherosclerotic vessel wall disease.
    Nörenberg D; Ebersberger HU; Diederichs G; Hamm B; Botnar RM; Makowski MR
    Eur Radiol; 2016 Mar; 26(3):910-20. PubMed ID: 26139316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where is the trace? Molecular imaging of vulnerable atherosclerotic plaques.
    Langer H; Schönberger T; Bigalke B; Gawaz M
    Semin Thromb Hemost; 2007 Mar; 33(2):151-8. PubMed ID: 17340463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.
    Laufer EM; Winkens HM; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):26-34. PubMed ID: 19182725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.
    Kusters DH; Tegtmeier J; Schurgers LJ; Reutelingsperger CP
    Mol Imaging Biol; 2012 Oct; 14(5):523-33. PubMed ID: 22983911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.
    Kowara M; Cudnoch-Jedrzejewska A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
    MacAskill MG; Newby DE; Tavares AAS
    Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of inflammation in atherosclerosis.
    Spagnoli LG; Bonanno E; Sangiorgi G; Mauriello A
    J Nucl Med; 2007 Nov; 48(11):1800-15. PubMed ID: 17942804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
    Chiorescu RM; Mocan M; Inceu AI; Buda AP; Blendea D; Vlaicu SI
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging atherosclerosis and risk of plaque rupture.
    Osborn EA; Jaffer FA
    Curr Atheroscler Rep; 2013 Oct; 15(10):359. PubMed ID: 23982263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
    Wang X; Peter K
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases.
    Gregersen I; Holm S; Dahl TB; Halvorsen B; Aukrust P
    Expert Rev Cardiovasc Ther; 2016; 14(3):391-403. PubMed ID: 26641944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of vascular inflammation.
    Tahara N; Tahara A; Honda A; Nitta Y; Kodama N; Yamagishi S; Imaizumi T
    Curr Pharm Des; 2014; 20(14):2439-47. PubMed ID: 23844819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the vulnerable patient with rupture-prone plaque.
    Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular signatures of atherosclerotic plaques: An up-dated panel of protein related markers.
    Eslava-Alcon S; Extremera-García MJ; González-Rovira A; Rosal-Vela A; Rojas-Torres M; Beltran-Camacho L; Sanchez-Gomar I; Jiménez-Palomares M; Alonso-Piñero JA; Conejero R; Doiz E; Olarte J; Foncubierta-Fernández A; Lozano E; García-Cozar FJ; Rodríguez-Piñero M; Alvarez-Llamas G; Duran-Ruiz MC
    J Proteomics; 2020 Jun; 221():103757. PubMed ID: 32247173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI, the technology for imaging of thrombi and inflammation.
    von Zur Muhlen C; Bode C
    Hamostaseologie; 2015; 35(3):252-62. PubMed ID: 25634650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
    Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
    Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.